Cullinan Oncology
CGEM
CGEM
173 hedge funds and large institutions have $931M invested in Cullinan Oncology in 2026 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 61 increasing their positions, 42 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
13% more funds holding
Funds holding: 153 → 173 (+20)
1.36% more ownership
Funds ownership: 106.96% → 108.32% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
173
Holding in Top 10
3
Calls
$2.92M
Puts
$978K
Top Buyers
| 1 | +$25.5M | |
| 2 | +$8.16M | |
| 3 | +$7.01M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$5.27M |
| 5 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$5.23M |
Top Sellers
| 1 | -$14.8M | |
| 2 | -$5.67M | |
| 3 | -$4.29M | |
| 4 |
Renaissance Technologies
New York
|
-$3.95M |
| 5 |
Goldman Sachs
New York
|
-$3.42M |
